WASHINGTON, DC, January 3, 2019: Morgan Lewis today debuts As Prescribed, the law firm’s new blog focused on the pharmaceutical and biotechnology sectors. As Prescribed explores the critical legal and regulatory developments impacting companies in these ever-evolving industries. The blog provides analysis from Morgan Lewis’s nationally recognized life sciences team on the latest regulations, rules, and court decisions as well as important litigation, transactions, and policy trends.
Visit As Prescribed here and follow us on social media using #ML_AsPrescribed.
Morgan Lewis handles a broad range of matters for clients in the life sciences industry—from innovation and emerging-business issues through research, development, and regulatory approval; marketing and distribution; product reimbursement; fraud, abuse, product liability, and intellectual property litigation; licensing and collaborations, mergers, acquisitions, and other corporate transactions; and outsourcing. Our comprehensive cross-practice life sciences team includes over 250 global partners and counsel, more than 60 of whom have advanced scientific degrees.